E-LIB Suche - Ergebnisse für: Desaiah, D.

1

Predictors of pharmacological treatment outcomes with atomo..:

Treuer, T. ; Feng, Q. ; Desaiah, D....
International Journal of Clinical Practice. 68 (2014) 9 - p. 1152-1160 , 2014

Link: https://doi.org/10.1111/..

2

O126 EVALUATION OF LY2157299 MONOHYDRATE (LY), A TGF-β RECE..:

Giannelli, G. ; Faivre, S. ; Santoro, A....
Journal of Hepatology. 60 (2014) 1 - p. S52-S53 , 2014

Link: https://doi.org/10.1016/..

3

A 12-month prospective, observational study of changes in f..:

Ershova, A. ; Yu, M. ; Desaiah, D...
Neuropsychiatrie de l'Enfance et de l'Adolescence. 60 (2012) 5 - p. S257 , 2012

Link: https://doi.org/10.1016/..

4

Efficacy and safety of duloxetine 60 mg once-daily in patie..:

Skljarevski, V. ; Zhang, S. ; Desaiah, D....
The Journal of Pain. 11 (2010) 4 - p. S38 , 2010

Link: https://doi.org/10.1016/..

5

Poster 6: Duloxetine 60 to 120 mg Once Daily Versus Placebo..:

Piezer, Kevin W. ; Belenkov, Yuri ; Brown, Jacques P....
PM&R. 1 (2009) 9S - p. , 2009

Link: https://doi.org/10.1016/..

6

O80 Évaluation de l'effet de la duloxétine dans la neuropat..:

Aboud, E. ; Bonnard, C. ; Chappell, A....
Diabetes & Metabolism. 35 (2009) - p. A21 , 2009

Link: https://doi.org/10.1016/..

7

Efficacy and safety of duloxetine in the treatment of pain ..:

Skljarevski, V. ; Chappell, A. ; Desaiah, D....
The Journal of Pain. 10 (2009) 4 - p. S35 , 2009

Link: https://doi.org/10.1016/..

8

P.1.c.012 Efficacy and safety of duloxetine 60-mg and 120-m..:

Brecht, S. ; Desaiah, D. ; Marechal, E....
European Neuropsychopharmacology. 19 (2009) - p. S258 , 2009

Link: https://doi.org/10.1016/..

9

P.2.c.023 Switching to duloxetine from SSRI non- and partia..:

Perahia, D. ; Quail, D. ; Desaiah, D...
European Neuropsychopharmacology. 17 (2007) - p. S353-S354 , 2007

Link: https://doi.org/10.1016/..

10

P.2.g.008 Patient vs physician assessed disease severity an..:

Demyttenaere, K. ; Croenlein, J. ; Petit, C...
European Neuropsychopharmacology. 17 (2007) - p. S395 , 2007

Link: https://doi.org/10.1016/..

11

P.2.c.027 The relevance of treating painful somatic symptom..:

Wise, T.N. ; Meyers, A.L. ; Desaiah, D....
European Neuropsychopharmacology. 17 (2007) - p. S356 , 2007

Link: https://doi.org/10.1016/..

12

Fire Ant Venom Alkaloid, Isosolenopsin A, a Potent and Sele..:

Yi, G. B. ; Mc Clendon, D. ; Desaiah, D....
International Journal of Toxicology. 22 (2003) 2 - p. 81-86 , 2003

Link: https://doi.org/10.1080/..

13

Effects of Manganese on Inositol Polyphosphate Receptors an..:

Chetty, C. S. ; Reddy, G. R. ; Suresh, A....
International Journal of Toxicology. 20 (2001) 5 - p. 275-280 , 2001

Link: https://doi.org/10.1080/..

14

Perinatal Lead Exposure Alters the Expression of Neuronal N..:

Chetty, C. S. ; Reddy, G. R. ; Murthy, K. S....
International Journal of Toxicology. 20 (2001) 3 - p. 113-120 , 2001

Link: https://doi.org/10.1080/..

15

Modulation of Calmodulin and Protein Kinase C Activities by..:

Pala, I. ; Srinivasan, A. ; Vig, P. J. S..
International Journal of Toxicology. 18 (1999) 2 - p. 91-96 , 1999

Link: https://doi.org/10.1080/..